Back to Search
ROSELLA BISSONNETTE, M.D.
M.D.
Obstetrics & Gynecology Physician
NPI: 1891227229IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 2017
Research & Publications (20)
Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.
PMID 19174580·Cancer Prev Res (Phila)·2009
7-preclinical
Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris.
PMID 19250161·J Cosmet Dermatol·2009
4-observational
Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.
PMID 18957410·J Biol Chem·2009
8-other
Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab.
PMID 19471949·Arch Dermatol Res·2009
3-trial
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
PMID 18294310·Br J Dermatol·2008
4-observational
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
PMID 19138958·Cancer Prev Res (Phila)·2008
7-preclinical
Protection afforded by sunscreens containing inorganic sunscreening agents against blue light sensitivity induced by aminolevulinic acid.
PMID 18798755·Dermatol Surg·2008
8-other
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study.
PMID 18424323·Lancet·2008
3-trial
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
PMID 18362934·Br J Cancer·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13001 E 17TH PL
AURORA, CO 80045 - Phone
- (303) 724-2052
Quick Facts
- NPI
- 1891227229
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile